Barbara A. Conley, M.D., is Associate Director of the Cancer Diagnosis Program (CDP) in the Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute. She is also a member of the Division’s Experimental Therapeutics Clinic. Her previous positions at the Institute included Chief of the CDP Diagnostics Research Branch, Senior Investigator in the Cancer Therapy and Evaluation Program Clinical Investigations Branch, and Head, Aerodigestive Diseases in the intramural Medicine Branch. Prior to her current appointment at DCTD, she was Chief of the Division of Hematology/Oncology at Michigan State University. She was a member of the faculty at the University of Maryland from 1987 to 1997. Dr. Conley has been the principal investigator on several NCI grants or contracts.
Dr. Conley holds an undergraduate degree from the University of Michigan and received her M.D. from Michigan State University. She is board-certified in Internal Medicine and Medical Oncology, and has research interests in diagnostic markers, drug development, and cancers of the aerodigestive tract. She has published extensively in many journals, and serves on the editorial board of several professional publications.